Rondo Therapeutics

Rondo Therapeutics, Inc. is a biopharmaceutical company exploring new frontiers in cancer treatment. Rondo Therapeutics is committed to advancing the field of immuno-oncology, focusing on treating solid tumors that are unresponsive to current therapies. Our solution is to create a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response while overcoming the suppressive tumor microenvironment.